Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study

AIM: In 9‐17‐year‐old Chinese girls, the AS04‐adjuvanted HPV‐16/18 vaccine (AS04‐HPV‐16/18) given as three‐dose schedule induced high antibody levels, which were noninferior 1 month after the third dose to those observed in 18‐25‐year‐old Chinese women in a large efficacy study. We assessed the pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuemei, Zhang, Xiang, He, Yilin, Ma, Zhilong, Xie, Yan, Lu, Xiangbin, Xu, Yabin, Zhang, Yanqiu, Jiang, Yunyu, Xiao, Hui, Struyf, Frank, Folschweiller, Nicolas, Jiang, Johny, Poncelet, Sylviane, Karkada, Naveen, Jastorff, Archana, Borys, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754390/
https://www.ncbi.nlm.nih.gov/pubmed/32780946
http://dx.doi.org/10.1111/ajco.13398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754390/
https://www.ncbi.nlm.nih.gov/pubmed/32780946
http://dx.doi.org/10.1111/ajco.13398

Ejemplares similares